Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas

PURPOSES: SMAD4/DPC4 mutations have been associated with aggressive behavior in pancreatic ductal adenocarcinomas (PDAC), and it has recently been suggested that RUNX3 expression combined with SMAD4 status may predict the metastatic potential of PDACs. We evaluated the prognostic utility of SMAD4/RU...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Lee, Yangkyu, Lee, Hyejung, Park, Hyunjin, Kim, Jin-Won, Hwang, Jin-Hyeok, Kim, Jaihwan, Yoon, Yoo-Seok, Han, Ho-Seong, Kim, Haeryoung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652736/
https://ncbi.nlm.nih.gov/pubmed/29100342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20815
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller